At Ubiquitome, our mission is to transform the fields of life science, biotech, and healthcare by providing cutting-edge solutions to tackle crucial challenges. Our revolutionary mobile real-time PCR device offers a portable, efficient, and gold-standard solution for molecular testing, particularly in resource-limited settings. In fact, our device has received FDA-EUA approval for the SalivaDirect protocol, enabling the detection of SARS-CoV-2 RNA, the virus responsible for COVID-19. This achievement marks a major milestone in our journey.